标题
Development of decoy oligonucleotide-warheaded chimeric molecules targeting STAT3
作者
关键词
-
出版物
BIOORGANIC & MEDICINAL CHEMISTRY
Volume 95, Issue -, Pages 117507
出版商
Elsevier BV
发表日期
2023-10-22
DOI
10.1016/j.bmc.2023.117507
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Current Status of Oligonucleotide-Based Protein Degraders
- (2023) Po-Chang Shih et al. Pharmaceutics
- Cyclic Peptides in Pipeline: What Future for These Great Molecules?
- (2023) Lia Costa et al. Pharmaceuticals
- PROTAC targeted protein degraders: the past is prologue
- (2022) Miklós Békés et al. NATURE REVIEWS DRUG DISCOVERY
- The role of the STAT3 signaling transduction pathways in radioresistance
- (2022) Po-Chang Shih PHARMACOLOGY & THERAPEUTICS
- Assessment of the Immunogenicity Potential for Oligonucleotide-Based Drugs
- (2022) Scott P. Henry et al. Nucleic Acid Therapeutics
- Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
- (2021) Suzan M Hammond et al. EMBO Molecular Medicine
- TF-PROTACs Enable Targeted Degradation of Transcription Factors
- (2021) Jing Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Development of Chimeric Molecules That Degrade the Estrogen Receptor Using Decoy Oligonucleotide Ligands
- (2021) Miyako Naganuma et al. ACS Medicinal Chemistry Letters
- Role of STAT3 signaling transduction pathways in cancer stem cell-associated chemoresistance
- (2020) Po-Chang Shih et al. DRUG DISCOVERY TODAY
- Pharmacokinetics and Proceedings in Clinical Application of Nucleic Acid Therapeutics
- (2020) Markus Herkt et al. MOLECULAR THERAPY
- Cereblon attenuates DNA damage-induced apoptosis by regulating the transcription-independent function of p53
- (2019) Liang Zhou et al. Cell Death & Disease
- A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
- (2019) Longchuan Bai et al. CANCER CELL
- Revisiting the development of small molecular inhibitors that directly target the signal transducer and activator of transcription 3 (STAT3) domains
- (2019) Po-Chang Shih LIFE SCIENCES
- First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
- (2012) Malabika Sen et al. Cancer Discovery
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More